Literature DB >> 21946405

Process of pulmonary rehabilitation and program organization.

E F M Wouters1, I M L Augustin.   

Abstract

Pulmonary rehabilitation programs are highly directed to return patients suffering from chronic lung diseases to a state of self-help. These programs are largely organized as temporary interventions in a highly fragmented delivery care system for patients with chronic respiratory conditions. In an optimal health care organizational structure, pulmonary rehabilitation needs to be considered as an essential part of an individualized, integrated care process, organized from the vantage point of the patient and the patients'health continuum. Pulmonary rehabilitation programs need to become organized as patient-centered care, respectful of and responsive to individual patient preferences, needs and values. Partnering and communication skills are considered as drivers for successful rehabilitation. Assessment is considered as the cornerstone to evaluate the individual needs and problems in order to develop an individualized intervention. Pulmonary rehabilitation programs need to move away from a supply-driven functional organizational structure towards integrated structures, including the full range of medical expertise, technical skills and specialized facilities needed to compete on added value in the management of patients with chronic respiratory diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21946405

Source DB:  PubMed          Journal:  Eur J Phys Rehabil Med        ISSN: 1973-9087            Impact factor:   2.874


  2 in total

Review 1.  Organizational aspects of pulmonary rehabilitation in chronic respiratory diseases.

Authors:  Martijn A Spruit; Emiel F M Wouters
Journal:  Respirology       Date:  2019-02-27       Impact factor: 6.424

2.  Multidimensional outcome assessment of pulmonary rehabilitation in traits-based clusters of COPD patients.

Authors:  Ingrid M L Augustin; Frits M E Franssen; Sarah Houben-Wilke; Daisy J A Janssen; Swetlana Gaffron; Herman-Jan Pennings; Frank W J M Smeenk; Willem R Pieters; Amber Hoogerwerf; Arent-Jan Michels; Frits van Merode; Emiel F M Wouters; Martijn A Spruit
Journal:  PLoS One       Date:  2022-02-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.